Home > NRC Library > ADAMS Public Documents
07-35398-01 601936 Prelude Therapeutics, Incorporated
Accession Number: ML17348A823
Date Released: Wednesday, February 14, 2018
Package Contents
The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.
- ML17348A824 - Prelude Therapeutics Incorporated Amendment Request Ltr. Dated December 1, 2017. (18 page(s), 12/1/2017)
- ML18018A850 - Prelude Therapeutics, Incorporated; E-mail dated 01/08/18 Subject: Request for Additional Information. (2 page(s), 1/8/2018)
- ML18030A766 - Prelude Therapeutics Incorporated, Deficiency Response Letter dtd January 15, 2018, Control No. 601936. (13 page(s), 1/15/2018)
- ML18037A977 - Prelude Therapeutics Incorporated, Cover Letter dtd January 29, 2018, for License Amendment No. 2, Control No. 601936. (3 page(s), 1/29/2018)
- ML18037B004 - Prelude Therapeutics Incorporated, License Amendment No. 2, Control No. 601936. (1 page(s), 1/29/2018)